1. Home
  2. NOTE vs BCTX Comparison

NOTE vs BCTX Comparison

Compare NOTE & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.22

Market Cap

24.7M

Sector

Technology

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.11

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTE
BCTX
Founded
2013
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.7M
28.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NOTE
BCTX
Price
$1.22
$4.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$29.25
$40.00
AVG Volume (30 Days)
261.7K
1.1M
Earning Date
03-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,673,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.60
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$4.04
52 Week High
$24.36
$98.20

Technical Indicators

Market Signals
Indicator
NOTE
BCTX
Relative Strength Index (RSI) 38.59 37.18
Support Level $1.17 $4.04
Resistance Level $1.29 $4.42
Average True Range (ATR) 0.12 0.28
MACD 0.00 0.12
Stochastic Oscillator 33.08 0.89

Price Performance

Historical Comparison
NOTE
BCTX

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: